Literature DB >> 22573411

Charles Bonnet syndrome and Terson's syndrome from subarachnoid hemorrhage: good news from bad news.

Colleen M Cebulla, Christopher Minning, Cedric Pratt, Martin Lubow.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22573411      PMCID: PMC3740348          DOI: 10.1007/s00417-012-2040-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  3 in total

1.  Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration.

Authors:  A Singh; T L Sørensen
Journal:  Br J Ophthalmol       Date:  2010-08-23       Impact factor: 4.638

2.  The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovascular age-related macular degeneration.

Authors:  Amardeep Singh; Torben L Sørensen
Journal:  Acta Ophthalmol       Date:  2010-11-25       Impact factor: 3.761

3.  Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).

Authors:  Emily J Abbott; Gillian B Connor; Paul H Artes; Richard V Abadi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

  3 in total
  1 in total

1.  Charles Bonnet syndrome and Terson's syndrome from subarachnoid hemorrhage: good news from bad news.

Authors:  Kelvin Z Li; Louis W Lim; Colin S H Tan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-28       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.